¿Qué tienen en común un neumático de alto rendimiento, una prótesis médica de última generación y el ADN que porta nuestra información genética? La respuesta reside en las teorías de un hombre que aprendió a “ve …
Paul Flory: El arquitecto de lo invisible que redefinió el mundo de los polímeros Read More »
The telehealth provider said hackers gained access to a third-party customer service platform, but medical records remained secure.
Hims & Hers says limited data stolen in social engineering attack Read More »
With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is advancing a treatment to compete with Edwards Lifesciences’ Evoque system.
VDyne secures FDA nod to start pivotal trial for tricuspid valve Read More »
Reid Wiseman, Victor Glover, Christina Koch y Jeremy Hansen, los astronautas de la misión Artemis 2 que viajan a bordo de una nave Orión, se han convertido en los humanos que más se han alejado de la Tierra, superando así el récord que desde 1970 y hasta ahora esta …
Récord de distancia a la Tierra de una nave tripulada Read More »
It’s the latest in a flurry of executive appointments from health insurers looking to strengthen their leadership teams amid regulatory headwinds and elevated medical costs.
Centene creates two new executive leadership roles Read More »
The deal positions Boston Scientific to compete with Medtronic for a market that analysts believe is highly under-penetrated.
Boston Scientific closes buyout of Valencia Technologies Read More »
The $18.3 billion acquisition by Blackstone and TPG is expected to close Tuesday.
Hologic CEO Steve MacMillan to retire after go-private deal Read More »
The Trump administration is requesting about $111 billion in discretionary funding for the HHS, nearly $16 billion less than its budget in 2026.
Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, AbbVie and others already use Claude in their operations.
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch Read More »
Some disease areas bucked the trend of shrinking pipelines, however, with immune and cardiovascular indications seeing an upward trend in investigational assets.
Pharma Pipeline Stalls for First Time in Decades: Citeline Read More »
